Carfilzomib T1795
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Carfilzomib is an irreversible proteasome inhibitor and antineoplastic agent that is used in treatment of refractory multiple myeloma.
CAS nr:
868540-17-4
Purity:
98%
Molecular Weight:
719,91
SMILES:
O1[C@@](C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN2CCOCC2)CCc2ccccc2)CC(C)C)Cc2ccccc2)CC(C)C)(C1)C
Formula:
C40H57N5O7
Pathway:
Proteases/Proteasome,Ubiquitination,Autophagy,Apoptosis
Target:
Proteasome,Proteasome,Autophagy,Apoptosis
